Detalles de la búsqueda
1.
Safety of shortened infusion times for combined ipilimumab and nivolumab.
Cancer Immunol Immunother
; 67(1): 135-140, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28988363
2.
Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma.
J Immunother Cancer
; 11(6)2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37286306
3.
Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during Lockdown.
Cancers (Basel)
; 14(10)2022 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35625961
4.
Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade.
Front Immunol
; 13: 906352, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35874702
5.
Diffuse PRAME Expression Is Highly Specific for Thin Melanomas in the Distinction from Severely Dysplastic Nevi but Does Not Distinguish Metastasizing from Non-Metastasizing Thin Melanomas.
Cancers (Basel)
; 13(15)2021 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34359765
6.
Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade.
PLoS One
; 14(8): e0221301, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31419253
Resultados
1 -
6
de 6
1
Próxima >
>>